Inventor · disambiguated record
Aranapakam Mudumbai Venkatesan
Also filed as: VENKATESAN ARANAPAKAM · VENKATESAN ARANAPAKAM M · VENKATESAN ARANAPAKAM MUDUMBAI
63 granted patents·30 pending applications·1,027 citations·filing 1992–2023
99Inventor score
Top patents by PatentIndex Score
93 records- 0195US5849735ATricyclic benzazepine vasopressin antagonistsAMERICAN CYANAMID CO·Filed 1995·Granted Dec 15, 1998·89 cites·40 claims
- 0294US6340691B1Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitorsAMERICAN CYANAMID CO·Filed 2000·Granted Jan 22, 2002·42 cites·5 claims
- 0393US5929097APreparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitorsAMERICAN CYANAMID CO·Filed 1997·Granted Jul 27, 1999·78 cites·11 claims
- 0493US5521173ATricyclic benzazepine vasopressin antagonistsAMERICAN HOME PROD·Filed 1995·Granted May 28, 1996·120 cites·28 claims
- 0592US8039469B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2009·Granted Oct 18, 2011·15 cites·17 claims
- 0691US10022381B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2015·Granted Jul 17, 2018·5 cites·6 claims
- 0791US8748421B2Triazine compounds as P13 kinase and MTOR inhibitorsWYETH LLC·Filed 2013·Granted Jun 10, 2014·11 cites·9 claims
- 0891US5536718ATricyclic benzazepine vasopressin antagonistsAMERICAN CYANAMID CO·Filed 1995·Granted Jul 16, 1996·86 cites·37 claims
- 0989US8859542B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2014·Granted Oct 14, 2014·9 cites·12 claims
- 1089US8575159B2Triazine compounds as PI3 kinase and mTOR inhibitorsPFIZER·Filed 2012·Granted Nov 5, 2013·9 cites·21 claims
- 1189US8217036B2Triazine compounds as PI3 kinase and mTOR inhibitorsVENKATESAN ARANAPAKAM MUDUMBAI·Filed 2011·Granted Jul 10, 2012·12 cites·10 claims
- 1288US11744897B2Folate receptor targeted nanoparticle drug conjugates and uses thereofELUCIDA ONCOLOGY INC·Filed 2022·Granted Sep 5, 2023·2 cites·30 claims
- 1388US5290780AAngiotensin II receptor blocking 2,3,6 substituted quinazolinonesAMERICAN CYANAMID CO·Filed 1992·Granted Mar 1, 1994·29 cites·5 claims
- 1486US7112582B2Bicyclic 6-alkylidene-penems as β-lactamase inhibitorsWYETH CORP·Filed 2003·Granted Sep 26, 2006·16 cites·57 claims
- 1586US6441023B1N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitorsAMERICAN CYANAMID CO·Filed 2001·Granted Aug 27, 2002·14 cites·9 claims
- 1685US9174963B2Triazine compounds as PI3 kinase and MTOR inhibitorsWYETH LLC·Filed 2014·Granted Nov 3, 2015·5 cites·2 claims
- 1785US7018997B2Tricyclic 6-alkylidene-penems as β-lactamase inhibitorsWYETH CORP·Filed 2003·Granted Mar 28, 2006·12 cites·44 claims
- 1885US5753648ATricyclic benzazepine vasopressin antagonistsAMERICAN CYANAMID CO·Filed 1996·Granted May 19, 1998·70 cites·36 claims
- 1984US8445486B2Triazine compounds as PI3 kinase and mTOR inhibitorsVENKATESAN ARANAPAKAM MUDUMBAI·Filed 2012·Granted May 21, 2013·5 cites·10 claims
- 2084US6197791B1N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitorsAMERICAN CYANAMID CO·Filed 1998·Granted Mar 6, 2001·52 cites·43 claims
- 2183US5294617AAngiotensin II receptor blocking 2,3,6 substituted quinazolinonesAMERICAN CYANAMID CO·Filed 1993·Granted Mar 15, 1994·26 cites·21 claims
- 2283US5281603AAngiotensin II receptor blocking 2,3,6 substituted quinazolinonesAMERICAN CYANAMID CO·Filed 1993·Granted Jan 25, 1994·24 cites·15 claims
- 2381US6342508B1N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitorsAMERICAN CYANAMID CO·Filed 2000·Granted Jan 29, 2002·10 cites·12 claims
- 2480US7148235B2Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depressionWYETH CORP·Filed 2005·Granted Dec 12, 2006·2 cites·5 claims
- 2578US7691842B2Tricyclic 6-alkylidene-penems as β-lactamase inhibitorsWYETH LLC·Filed 2008·Granted Apr 6, 2010·2 cites·36 claims
- 2678US6462073B2N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitorsAMERICAN CYANAMID CO·Filed 2001·Granted Oct 8, 2002·4 cites·9 claims
- 2778US5358951AAngiotensin II receptor blocking 2, 3, 6 substituted quinazolinonesAMERICAN CYANAMID CO·Filed 1993·Granted Oct 25, 1994·19 cites·56 claims
- 2877US6358980B1Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitorsAMERICAN CYANAMID CO·Filed 2000·Granted Mar 19, 2002·8 cites·5 claims
- 2977US6331563B1N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl, Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase inhibitorsFiled 2000·Granted Dec 18, 2001·5 cites·9 claims
- 3077US5436333AProcess for the preparation of tricyclic-heterocyclesAMERICAN CYANAMID CO·Filed 1994·Granted Jul 25, 1995·15 cites·7 claims
- 3176US6753337B2Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitorsWYETH CORP·Filed 2001·Granted Jun 22, 2004·5 cites·5 claims
- 3276US6288086B1N-hydroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitorsAMERICAN CYANAMID CO·Filed 2000·Granted Sep 11, 2001·3 cites·9 claims
- 3374US11957760B2Folate receptor targeted nanoparticle drug conjugates and uses thereofELUCIDA ONCOLOGY INC·Filed 2023·Granted Apr 16, 2024·0 cites·30 claims
- 3473US6444704B1N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitorsAMERICAN HOME PROD·Filed 2000·Granted Sep 3, 2002·8 cites·10 claims
- 3573US5780471ATricyclic benzazepine vasopressin antagonistsAMERICAN CYANAMID CO·Filed 1996·Granted Jul 14, 1998·29 cites·10 claims
- 3673US5532235ATricyclic benzazepine vasopressin antagonistsAMERICAN CYANAMID CO·Filed 1995·Granted Jul 2, 1996·35 cites·20 claims
- 3773US5281604AAngiotensin II receptor blocking 2,3,6-substituted quinazolinonesAMERICAN CYANAMID CO·Filed 1993·Granted Jan 25, 1994·12 cites·21 claims
- 3872US6172057B1N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitorsAMERICAN CYANAMID CO·Filed 1998·Granted Jan 9, 2001·36 cites·23 claims
- 3971US5284853AAngiotensin II receptor blocking 2,3,6 substituted quinazolinonesAMERICAN CYANAMID CO·Filed 1993·Granted Feb 8, 1994·12 cites·21 claims
- 4070US7235569B2Piperidinyl indole and tetrohydropyridinyl indole derivatives and method of their useWYETH CORP·Filed 2004·Granted Jun 26, 2007·4 cites·8 claims
- 4170US2023241243A1Carrier particle-drug conjugates, self-immolative linkers, and uses thereofELUCIDA ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 4269US7276603B2Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their useWYETH CORP·Filed 2004·Granted Oct 2, 2007·5 cites·1 claims
- 4366US5700796ATricyclic benzazepine vasopressin antagonistsAMERICAN CYANAMID CO·Filed 1996·Granted Dec 23, 1997·20 cites·18 claims
- 4464US5914339ASubstituted 1,3-benzodioxolesAMERICAN HOME PROD·Filed 1997·Granted Jun 22, 1999·10 cites·87 claims
- 4562US7332506B2Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depressionWYETH CORP·Filed 2006·Granted Feb 19, 2008·0 cites·2 claims
- 4662US5610156ATricyclic benzazepine vasopressin antagonistsAMERICAN CYANAMID CO·Filed 1995·Granted Mar 11, 1997·14 cites·6 claims
- 4762US5292742AAngiotensin II receptor blocking 2,3,6 substituted quinazolinonesAMERICAN CYANAMID CO·Filed 1993·Granted Mar 8, 1994·7 cites·22 claims
- 4861US7812014B2Bicyclic 6-alkylidene-penems as β-lactamase inhibitorsWYETH LLC·Filed 2008·Granted Oct 12, 2010·0 cites·31 claims
- 4961US7276611B2Process for synthesizing beta-lactamase inhibitor intermediatesWYETH CORP·Filed 2004·Granted Oct 2, 2007·1 cites·19 claims
- 5060US6825354B2Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and TACE inhibitorsWYETH CORP·Filed 2001·Granted Nov 30, 2004·1 cites·5 claims
Showing the top 50 of 93 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →